Bibliographical note

Funding Information:
Author Henning reports grants from the LEO Foundation , Denmark (number LF 18002 ), during the conduct of the study. Dr Jemec reports personal fees from AbbVie, Coloplast, Chemocentryx, LEO Pharma, Incyte, InflaRx, Novartis, UCB, Kymera, and VielaBio and grants from AbbVie , LEO Foundation , Afyx , InflaRx , Janssen-Cilag , Novartis , UCB , CSL Behring , Regeneron , and Sanofi outside the submitted work. Drs Ibler, Jennum, Ullum, Erikstrup, Nielsen, Hjalgrim, Sørensen, Thørner, and Pedersen and Authors Loft, Didriksen, Bruun, and Dinh have no conflicts of interest to declare.

Funding Information:
Funding sources: Supported by a research grant from LEO Foundation, Denmark (number LF 18002 to MH). No study sponsor or funder has taken part in the current study from the conception of idea to the submission of this manuscript. All study authors have worked independently of sponsors or funders, and all authors have access to the data and can take responsibility for the integrity and the accuracy of the data.